Sees FY23 adjusted EBITDA at mid to high end of $1.85B-$2B range. IFF continues to execute its portfolio optimization initiatives, most recently through the announced sale of its Cosmetic Ingredients business unit for $810M, which the Company continues to believe will close in the first quarter of 2024. The Company continues to progress additional divesture actions to strengthen its overall capital structure.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IFF:
